The p53-mediated transcriptional repression of SLC7A11 contributed to ROS-induced ferroptosis.21 BAP1 represses SLC7A11 expression, leading to ferroptosis induction.22 Currently, ferroptosis-inducing drugs are attracting more attention for cancer treatment and will hopefully provide a potential strategy for cancer therapy. This evidence concerns the gene SLC7A11 and cancer.